Proxy adviser recommends Caremark reject CVS
694352
Proxy advisory firm Glass Lewis said on Friday it recommended that shareholders of Caremark Rx Inc.  reject the planned $24 billion takeover by drug-store chain CVS Corp.
56048
Let the patient beware. Going outside your insurerâs network of preferred doctors or hospitals could be more hazardous to your financial health than you suspected.
488144
Here's how to avoid biases in investing -- and in the doctor's office.
230314
Government advisers on Thursday rejected Merck & Co.'s bid for over-the-counter sales of Mevacor, the granddaddy of the famed cholesterol-lowering drugs.
641808
Pfizer tries to stop patients from switching to generic Zocor.
556043
A company that does a poor job of bringing in cash, even if it's selling lots of stuff, should be avoided.
337209
Pharmacy benefits manager Express  Scripts Inc.  is planning to make a $26 billion hostile  bid on Monday for rival Caremark RX , the New York Times  reported on its Web site, citing people briefed on the  company's plan.
513518
Proxy advisory firm Glass Lewis said on Friday it recommended that shareholders of Caremark Rx Inc.  rejected the planned $24 billion takeover by drug-store chain CVS Corp.
275903
A U.S. advisory panel  urged the government on Thursday to reject Merck & Co Inc's   latest bid to sell a cholesterol-lowering drug without  a prescription.
649369
A broker wants to help you retire early? Be careful.
208309
CVS Corp.  is likely to  raise its $23.4 billion offer for Caremark Rx Inc. CMX.N>, but  rival suitor Express Scripts Inc.  may still have more  money to throw into the bidding war, sources familiar with the  situation said on Thursday.
733661
Caremark Rx Inc.  said on  Thursday its board supported a sweetened $23.5 billion takeover  bid from CVS Corp.  and rebuffed a hostile $26.9 billion  offer from rival Express Scripts Inc.
275831
CVS Corp.  sweetened its bid for Caremark Rx Inc.  on Tuesday by tripling a proposed special cash dividend for the prescription drug benefit manager's stockholders to $6 per share, after proxy advisory firms urged rejection of the previous offer.
622731
U.S. pharmacy benefits manager Express Scripts Inc.  is preparing a $26 billion bid for rival Caremark RX , topping an offer made last month by drugstore chain CVS Corp. , newspaper reports said on Monday.
281686
A Delaware Chancery Court judge said on Friday that Caremark Rx Inc.  must delay a shareholder vote until the pharmacy benefit manager provides more details on its planned acquisition by CVS Corp.
687262
A U.S. advisory panel on Friday urged regulators to reject over-the-counter sales of Merck & Co. Inc.'s  cholesterol-lowering drug Mevacor.
73292
Federal advisers rejected Merck &amp; Co.'s quest to become the first American drug maker to sell cholesterol-fighting statins over the counter, saying the company's own studies raised potential health risks while offering modest life-saving benefits.